Introduction
The diagnosis of thyroid cancer has shifted over time, changing from a relatively simple classification during the 1960s and 1970s (1) to highly complicated subclassifications more recently (2) . The follicular variant (FV) is one of the most common variants of papillary thyroid carcinoma (PTC), occurring in approximately 20-40% (3, 4) of PTC patients, with an incidence of FV increasing exponentially over time (5, 6) . The most reliable morphological criteria for the diagnosis of this malignancy are papillary carcinoma nuclear features and tumor capsule invasion or infiltration. Clinically, FVPTC has been suggested to be more similar to minimally invasive follicular thyroid cancer, a low-risk lesion, than to conventional PTC (7) (8) (9) (10) (11) . Moreover, the recent publication of an integrated genomic characterization (The Cancer Genome Atlas-TGCA) of papillary thyroid carcinoma assists pathologists in identifying molecular similarities and differences between the various subtypes of thyroid malignancy (1) .
The encapsulated forms of FVPTC (EFVPTC) represent a group of thyroid tumors with an overall good prognosis (12) in terms of an indolent disease course with an extremely low recurrence rate, likely to be less than 1% within the first 15 years. Therefore, EFVPTC with encapsulation or clear demarcation, follicular growth pattern with less than 1% of papillae, no psammoma bodies, less than 30% of solid/trabecular/insular growth pattern and nuclear score 2-3, absence of vascular or capsular invasion, absence of tumor necrosis and low mitotic activity have been recently reclassified as "non-invasive follicular neoplasm with papillary-like nuclear features (NIFTP)" (13).
The objective of the present study was to identify a specific NIFTP molecular signature distinct from that of follicular adenomas and infiltrative FVPTCs by using the nanoString mRNA expression analysis and the uncorrelated shrunken centroid (USC) machine-learning algorithm.
Materials and Methods

Study group
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RNA purification
Total RNA was purified from 18 FAs, 26 NIFTPs and 18 infiltrative FVPTCs (IFVPTCs). After a standard deparaffinization procedure was performed, 2-3 formalin-fixed, paraffinembedded (FFPE) tissue sections (5 μm in thickness) were submitted to manual microdissection. Then, RNA was extracted and purified using a Qiagen RNeasy FFPE kit (Qiagen, Hilden, Germany), according to the manufacturer's recommendations. RNA concentrations were measured using an Xpose instrument (Trinean, Gentbrugge, Belgium).
NanoString nCounter assay
The nCounter custom code set used in this study was designed and synthesized by nanoString Technologies (nanoString Technologies, Seattle, Washington, USA). A total of 75 genes were included in the code set based on their observed differential expression between both FAs vs FVPTCs/PTCs and FAs vs FTCs ( including sample preparation, hybridization, detection, and scanning, were performed following the manufacturer's instructions. Gene expression profiling using nanoString was performed on RNA extracted from the 62 thyroid neoplasms. Raw data normalization was performed in 2 steps, as previously reported (26) .
DNA extraction and BRAF and RAS gene family mutational analyses
Two unstained 10-µm paraffin sections from each sample were first deparaffinized with xylene prior to DNA purification using a DNeasy FFPE kit (Qiagen, Hilden, Germany), according to the manufacturer's instructions. This paper has been peer-reviewed and accepted for publication, but has yet to undergo copyediting and proof correction. The final published version may differ from this proof.
DNA sequencing on a 3130 Genetic Analyzer (Thermo Fisher Scientific, Waltham, Massachusetts, USA).
Unsupervised sample clustering by Pearson's correlation and non-negative matrix factorization (NMF)
All the gene expression profiles were used as input for both Pearson and NMF methods.
To group the samples by related gene expression profiles, cluster analyses were performed using Pearson's correlation by the average linkage method between samples and genes on the normalized data (26) .
NMF was employed to identify stable sample clusters. The NMF parameters were as follows: rank, k = 2 to k = 6 clusters; number of runs to build consensus matrix = 15; error function = divergence; and maximum interactions = 1000. The optimal clustering result was determined using the higher cophenetic correlation value between the clusters.
Sample classification by uncorrelated shrunken centroids
The samples were classified by expression profiling from the normalized counts for each analyzed gene using the uncorrelated shrunken centroid (USC) algorithm (27) . This algorithm includes two steps: the training step and the test step. The aim of this algorithm is to build a "classifier" using the given training set and to use the classifier to predict the classes of the test set.
The first step, or training set, cross-validated the capability of the model to correctly classify the samples regarding the fixed reference classes of samples over a range of parameters (shrinkage threshold Δ and correlation threshold ρ).
The second step involved the use of the classifier to predict the class to which the unknown samples belonged or to identify the most similar class based on phenotypic characteristics.
In our study, the datasets of the FA and IFVPTC samples were considered as the two reference classes in the training set. The test set included the NIFTP samples, for which the classes were assumed to be unknown to the algorithm. For computing purposes, we fixed a maximum Δ threshold of 10 and a minimum ρ threshold of 0.5 (correlation step 0.1), and This paper has been peer-reviewed and accepted for publication, but has yet to undergo copyediting and proof correction. The final published version may differ from this proof.
we performed a 10-fold cross validation. The cross validation was run 15 times to obtain a reliable quantification of errors. Hence, we tested the chosen training sets on the test set. This paper has been peer-reviewed and accepted for publication, but has yet to undergo copyediting and proof correction. The final published version may differ from this proof.
Results
Study group
A total of 62 cases were eligible for study inclusion: 18 adenomas, 18 IFVPTCs ( Figure 1A) and 26 NIFTP (3) ( Figure 1B) . All cases exhibited a complete follicular growth pattern and a total absence of thyroiditis. Each tumor had more than 60% neoplastic cells.
Sample genotyping
Overall, mutations were identified in 13 (50.0%) of the 26 NIFTPs and 10 (62.5%) of the 16
IFVPTCs (two IFVPTCs could not be analyzed).
Specifically, among the NIFTPs, the 13 mutated samples included 1 BRAF(V600E), 3 BRAF (K601E), 6 NRAS (Q61R) and 3 HRAS (Q61R) mutations. Finally, among the IFVPTCs, the 10 mutated samples had 5 BRAF (V600E), 4 NRAS (Q61R) and 1 HRAS (Q61R) mutations.
Data normalization and sample clustering
None of the samples were excluded after data normalization. Figure 2 shows the sample clusters obtained using the entire code set without data reduction. NMF analysis showed a higher cophenetic correlation (0.9844) for rank 2 than for the two-cluster model,
indicating the former to be more stable (data not shown). Specifically, by Pearson clustering, the two sample clusters showed correlations of r=0.23 for the left-sided cluster (C1) and r=0.30 for the right-sided cluster (C2 This paper has been peer-reviewed and accepted for publication, but has yet to undergo copyediting and proof correction. The final published version may differ from this proof.
USC training set
The training set cross-validation generates a list of results that report the accuracy (i.e., the number of errors) of the classification and the average number of genes used for the classification together with the shrinkage threshold (Δ) and the correlation threshold (ρ).
Briefly, we selected the 27-gene classifier because it generated the lowest number of 
USC test set
The NIFTP samples were classified using the previously described classifier. Table 2 includes a summary of the classification results, indicating the class assigned, the discriminant score for the assignment (e.g., sample x is assigned to class k with the minimum discriminant score), and the sample genotypes. In brief, the 27-gene model In the present study, we investigated the expression profile of NIFTPs in comparison to those of adenomas and infiltrative follicular variants of PTC. The aim was to describe the expression signature of this new class of neoplasm by defining a list of genes that may be able to characterize it from a molecular standpoint. In particular, we applied customized NanoString expression analysis, which does not require retro-transcription or amplification.
Our results revealed distinct expression profiles for FAs and IFVPTCs that resulted in the mutations (35) than that of BRAF(V600E), which has been associated with infiltrative and more aggressive tumors (36, 37) . Surprisingly, in our series, we also found an NIFTP with a BRAF (V600E) mutation. For this reason, the case was re-studied by two additional trained pathologists in an independent manner. The case was sampled in toto. The entire lesional capsule was re-evaluated but appeared intact. New sections from paraffin blocks were prepared, but the tumor capsule was not infiltrated (Figure 3 ). No clear papillae nor wide solid areas were found. This unusual observation could be explained by taking into account two different considerations: 1) in rare cases NIFTP could harbor a BRAF (V600E) mutation as a preinfiltrative lesion; 2) there is an important technical limitation for pathologists with regard to the identification of capsular and/or vascular invasion, as it is essentially impossible to completely evaluate the tumor capsule (1, 38) .
Once the genetic and mRNA heterogeneity of NIFTPs was apparent, we tried to further validate the results with a machine-learning classification approach using the USC algorithm (27) . This algorithm allows the identification of small subgroups of genes and is capable of discriminating between classes without making any preliminary assumptions from the data. In this manner, we chose a 27-gene classifier because of its good performance on the training set of samples. Next, we tested the NIFTP (test) set and the 27-gene classifier, which assigned 50% of NIFTPs as IFVPTCs and 50% of NIFTPs as FAs.
Therefore, 13 NIFTPs were classified as IFVPTCs by a molecular/statistical tool.
Furthermore, the majority of the IFVPTC-assigned samples (84.64%) were mutationpositive.
As reported in the study of Nikiforov et al. (13) in which NIFTPs with mutations in BRAF, RAS or other genes were considered precursors of infiltrative lesions, our data support that mutated NIFTPs also exhibit a likely malignant expression profile (NIFTP-LM). These data reinforce the hypothesis that they might represent a precursor of IFVPTC. In contrast, wild-type NIFTP with an adenoma-like gene expression profile (NIFTP-LA) might represent the so-called "benign counterpart" of these neoplasms (Figure 4) .
From a pragmatic standpoint, these results could be prospectively applied in clinical practice, with particular regard to pre-surgical fine-needle aspiration biopsy (FNAB). In fact, it is widely accepted that NIFTPs cannot be identified with certainty by fine-needle This paper has been peer-reviewed and accepted for publication, but has yet to undergo copyediting and proof correction. The final published version may differ from this proof.
aspiration cytology because their nuclear features are quite similar to those of infiltrative follicular variant papillary carcinomas (39) .
In conclusion, we suggest that our classifier, in addition to a genotyping analysis (34), could be used for nodules with indeterminate diagnoses by cytology to obtain additional data that might be useful for the diagnostic and prognostic characterization of these tumors. In fact, because of the benign clinical behavior of NIFTPs, preoperative recognition of these neoplasms would have important implications for the therapeutic and surgical strategies employed to avoid patient overtreatment (39, 40) . This paper has been peer-reviewed and accepted for publication, but has yet to undergo copyediting and proof correction. The final published version may differ from this proof. This paper has been peer-reviewed and accepted for publication, but has yet to undergo copyediting and proof correction. The final published version may differ from this proof. This paper has been peer-reviewed and accepted for publication, but has yet to undergo copyediting and proof correction. The final published version may differ from this proof. 
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